Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Sponsor: Revolution Medicines, Inc.
Summary
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with Standard(s) of Care (SOC) or with novel agents. The current subprotocols include the following: Subprotocol A: RMC-6236 + 5-fluorouracil-based regimens Subprotocol B: RMC-6236 + cetuximab with or without mFOLFOX6 Subprotocol C: RMC-6236 + gemcitabine + nab-paclitaxel Subprotocol D: RMC-9805 with or without RMC-6236 + 5-fluorouracil-based regimens Subprotocol E: RMC-9805 with or without RMC-6236 + cetuximab with or without mFOLFOX6 Subprotocol F: RMC-9805 with or without RMC-6236 + gemcitabine + nab-paclitaxel
Official title: A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1130
Start Date
2024-05-24
Completion Date
2027-07-15
Last Updated
2026-04-01
Healthy Volunteers
No
Conditions
Interventions
RMC-6236
Oral tablet
mFOLFOX6 regimen
IV infusion
bevacizumab
IV infusion
mFOLFIRINOX regimen
IV infusion
cetuximab
IV infusion
gemcitabine
IV infusion
nab-paclitaxel
IV infusion
RMC-9805
Oral Tablet
Locations (32)
Ironwood Cancer and Research Centers
Chandler, Arizona, United States
Mayo Clinic Hospital
Phoenix, Arizona, United States
HonorHealth Research Institute
Scottsdale, Arizona, United States
UC San Diego Moores Cancer Center
La Jolla, California, United States
Cedars-Sinai Cancer at Cedars-Sinai Medical Center
Los Angeles, California, United States
UCLA Hematology/Oncology- Santa Monica
Los Angeles, California, United States
University of Colorado Hospital-Anschutz Cancer Pavilion
Aurora, Colorado, United States
Yale-New Haven Hospital-Yale Cancer Center
New Haven, Connecticut, United States
Mayo Clinic Cancer Center
Jacksonville, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
The University of Kansas Clinical Research Center
Westwood, Kansas, United States
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Mayo Clinic
Rochester, Minnesota, United States
Nebraska Cancer Specialists
Omaha, Nebraska, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Atlantic Health System
Morristown, New Jersey, United States
Northwell Health / RJ Zuckerberg Cancer Center
Lake Success, New York, United States
Columbia University Medical Center
New York, New York, United States
Memorial Sloan Kettering Cancer Center Main Campus
New York, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
SCRI Oncology Partners
Nashville, Tennessee, United States
Baylor College of Medicine
Houston, Texas, United States
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
NEXT Oncology Dallas
Irving, Texas, United States
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, United States
Virginia Cancer Specialists
Fairfax, Virginia, United States
Fred Hutchinson Cancer Center
Seattle, Washington, United States